peptide sciences glp-1 Diagram of how glucagon-like pep | Stock Image Sai Life Sciences: GLP-1 boom
Description
Qsymia is approved for chronic weight management, unlike phentermine monotherapy which has only short-term approval
DOI: 10.1038/s44360-026-00108-y The authors report no outside funding
What can be said with reasonable confidence is this
Additionally, Wang et al
Participants receiving 2.4 mg of Sema weekly, alongside lifestyle modifications, experienced an average 14.9% reduction in body weight over 68 weekssubstantially more than the placebo group
